Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Ghalamfarsa, Ghasem  [Clear All Filters]
2020
Salimifard S, Masjedi A, Hojjat-Farsangi M, Ghalamfarsa G, Irandoust M, Azizi G, Mohammadi H, Keramati MReza, Jadidi-Niaragh F. Cancer associated fibroblasts as novel promising therapeutic targets in breast cancer. Pathol Res Pract. 2020:152915.
Nikkhoo A, Rostami N, Farhadi S, Esmaily M, Ardebili SMoghadasza, Atyabi F, Baghaei M, Haghnavaz N, Yousefi M, Aliparasti MReza, et al. Codelivery of STAT3 siRNA and BV6 by carboxymethyl dextran trimethyl chitosan nanoparticles suppresses cancer cell progression. Int J Pharm. 2020:119236.
Hashemi V, Farhadi S, Chaleshtari MGhasemi, Seashore-Ludlow B, Masjedi A, Hojjat-Farsangi M, Namdar A, Ajjoolabady A, Mohammadi H, Ghalamfarsa G, et al. Nanomedicine for improvement of dendritic cell-based cancer immunotherapy. Int Immunopharmacol. 2020;83:106446.
Hajizadeh F, Ardebili SMoghadasza, Moornani MBaghi, Masjedi A, Atyabi F, Kiani M, Namdar A, Karpisheh V, Izadi S, Baradaran B, et al. Silencing of HIF-1α/CD73 axis by siRNA-loaded TAT-chitosan-spion nanoparticles robustly blocks cancer cell progression. Eur J Pharmacol. 2020:173235.
Masjedi A, Ahmadi A, Atyabi F, Farhadi S, Irandoust M, Khazaei-Poul Y, Chaleshtari MGhasemi, Fathabad MEdalati, Baghaei M, Haghnavaz N, et al. Silencing of IL-6 and STAT3 by siRNA loaded hyaluronate-N,N,N-trimethyl chitosan nanoparticles potently reduces cancer cell progression. Int J Biol Macromol. 2020.
Hashemi V, Ahmadi A, Malakotikhah F, Chaleshtari MGhasemi, Moornani MBaghi, Masjedi A, Sojoodi M, Atyabi F, Nikkhoo A, Rostami N, et al. Silencing of p68 and STAT3 synergistically diminishes cancer progression. Life Sci. 2020:117499.